The molecular diagnostic laboratory provides quantitative polymerase chain reaction (PCR), mutation analysis and gene sequencing to support therapy selection, treatment monitoring and minimal residual disease detection with a complete range of clinically actionable tests; Provided as part of MPLN's evidence based comprehensive strategic reflex testing protocol or can be ordered individually. Molecular Diagnostics Flyer (DEC2018)
A-Z Molecular Diagnostic Oncology Tests
ABL Kinase Gene Mutation Analysis; Gleevec® Resistance*
B-cell IGH Gene Rearrangement by Next Generation Sequencing
BCR/ABL qRT PCR, Major p210 and Minor p190 Mutations, Minimal Residual Disease
BRAF Mutation Analysis by Next Generation Sequencing
Chlamydia Trachomatis (CT), Qualitative by Aptima COMBO® 2 TMA
Colon Cancer Panel by Next Generation Sequencing
EGFR Mutation Analysis by Next Generation Sequencing
GIST Panel - KIT, PDGFRA by Next Generation Sequencing
Herpes Simplex Virus (HSV) Type 1 and 2 Qualitative by PCR
Human Papillomavirus (HPV) Genotyping
Human Papillomavirus (HPV) High Risk by Aptima HPV
IDH1/IDH2 Mutation Analysis by Next Generation Sequencing
IgVH Somatic Hypermutation by Next Generation Sequencing
JAK2 V617F Mutation Analysis by PCR
← prev 2 next →